脊柱关节炎患者报告结局测量工具的测量性能:一项系统评价
该系统评价遵循PRISMA指南,检索截至2017年6月30日发表的研究,从125项研究中识别出60种患者报告结局测量工具(PROMs),并按COSMIN标准评估其方法学质量和证据水平。结果显示假设检验(82.4%)和信度(60.0%)研究最多,分别有77.7%和42.7%的研究达到「尚可」及以上方法学质量;41.7%的PROMs仅在强直性脊柱炎中研究,23.3%仅在银屑病关节炎中研究。结论指出缺乏跨脊柱关节炎亚型验证的PROMs,未来研究可考虑跨不同亚型验证PROMs。
要点
- 从125项研究中识别出60种PROMs,仅21种在两种及以上脊柱关节炎亚型中验证。
- 假设检验和信度研究最多,分别有77.7%和42.7%达到「尚可」及以上方法学质量。
- 结论指出缺乏跨脊柱关节炎亚型验证的PROMs,未来研究可考虑跨亚型验证。
核心结论
- 该系统评价识别出60种PROMs并汇总其测量性能证据。
- 目前缺乏跨脊柱关节炎亚型使用的PROMs验证。
- 未来研究可考虑验证PROMs在不同脊柱关节炎亚型中的使用。
研究设计与样本
- 系统评价遵循PRISMA指南,检索PubMed、Embase和PsychINFO(Ovid)中2017年6月30日前发表的文章。
- 共纳入125项研究,来自39个国家,识别出60种PROMs。
- 按COSMIN推荐评估方法学质量和证据水平。
主要发现
- 文献中假设检验研究最多(82.4%),其次为信度研究(60.0%)。
- 评估假设检验和信度的研究中,分别有77.7%和42.7%具有「尚可」或更好的方法学质量。
- 41.7%的PROMs仅在强直性脊柱炎中研究,23.3%仅在银屑病关节炎中研究。
- 21种PROMs在两种或以上脊柱关节炎亚型中验证。
- 评估较广泛的PROMs包括强直性脊柱炎的ASQoL和BASFI,以及银屑病关节炎的VITACORA-19。
关键数值与推荐
- 从125项研究中识别出60种PROMs。
- 假设检验研究占82.4%,信度研究占60.0%。
- 假设检验和信度研究中分别有77.7%和42.7%具有「尚可」或更好方法学质量。
- 41.7%的PROMs仅在强直性脊柱炎中研究,23.3%仅在银屑病关节炎中研究。
- 21种PROMs在两种或以上脊柱关节炎亚型中验证。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This systematic review aimed to identify studies investigating measurement properties of patient reported outcome measures (PROMs) for spondyloarthritis (SpA), and to evaluate their methodological quality and level of evidence relating to the measurement properties of PROMs. METHODS: This systematic review was guided by the preferred reporting items for systematic review and meta-analysis (PRISMA). Articles published before 30 June 2017 were retrieved from PubMed®, Embase®, and PsychINFO® (Ovid). Methodological quality and level of evidence were evaluated according to recommendations from the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN). RESULTS: We identified 60 unique PROMs from 125 studies in 39 countries. Twenty-one PROMs were validated for two or more SpA subtypes. The literature examined hypothesis testing (82.4%) most frequently followed by reliability (60.0%). A percentage of 77.7% and 42.7% of studies that assessed PROMs for hypothesis testing and reliability, respectively had "fair" or better methodological quality. Among the PROMs identified, 41.7% were studied in ankylosing spondylitis (AS) only and 23.3% were studied in psoriatic arthritis (PsA) only. The more extensively assessed PROMs included the ankylosing spondylitis quality of life (ASQoL) and bath ankylosing spondylitis functional index (BASFI) for ankylosing spondylitis, and the psoriatic arthritis quality of life questionnaire (VITACORA-19) for psoriatic arthritis. CONCLUSION: This study identified 60 unique PROMs through a systematic review and synthesized evidence of the measurement properties of the PROMs. There is a lack of validation of PROMs for use across SpA subtypes. Future studies may consider validating PROMs for use across different SpA subtypes.
引用
- Png K, Kwan YH, Leung YY, et al. Measurement properties of patient reported outcome measures for spondyloarthritis: A systematic review. Semin Arthritis Rheum. 2018. PMID: 29573848. doi:10.1016/j.semarthrit.2018.02.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。